Astellas Pharma Inc. ( ALPMY) - Key Metrics
ALPMY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | ? | ? | ? | ? |
| 2026Q3 | $318.89 | $56.01 | $42.30 | $34 |
| 2026Q2 | $292.73 | $44.22 | $128.12 | $120.62 |
| 2026Q1 | $281.72 | $38.11 | $30.54 | $23.41 |
| 2024Q4 | $256.56 | $41.84 | $57.45 | $52.03 |
ALPMY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | ? | ? |
| 2026Q3 | 69.63% | 9.34 |
| 2026Q2 | 88.19% | 9.05 |
| 2026Q1 | 96.81% | 9.29 |
| 2024Q4 | 88.44% | 8.64 |
ALPMY Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q4 | 4.14% | ? |
| 2026Q3 | 1.60% | 1.86% |
| 2026Q2 | 7.75% | 2.44% |
| 2026Q1 | 1.67% | 2.60% |
| 2024Q4 | 3.47% | 2.56% |
ALPMY
Price: $13.54
Dividend Yield: 3.12%
Forward Dividend Yield: 6.11%
Dividend Per Share: 0.83 USD
Earnings Per Share: 1.02 USD
P/E Ratio: 13.70
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 25.2 billion
Average Dividend Frequency: 3
Years Paying Dividends: 18
DGR3: 7.50%
DGR5: 9.03%
DGR10: 6.35%